A new perspective on what could arguably be one of the biggest stories in pharmacology of the last decade. While GLP-1 receptor agonists have received significant attention, the development of new small-molecule agonists with improved brain penetration could open up new therapeutic applications beyond obesity and diabetes. A New Era of Brain Therapeutics…
Discover how GLP-1 receptor agonists could offer new treatment possibilities beyond obesity and diabetes, including potential applications in addiction and dementia. Explore innovative therapeutic approaches, from gene therapy and novel drug targets to psychedelics and new ways of delivering treatments across the blood–brain barrier.
Featuring expert perspectives and short talks showcasing emerging research, this event offers an opportunity to broaden your knowledge, discover exciting developments across neuroscience and pharmacology, and connect with a community working to advance the next generation of brain therapies.
Featuring:
Stefan Trapp
